http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6783974-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-6783974-B1 |
titleOfInvention | Pyrimidine compound or salt thereof |
abstract | Provided are a novel pyrimidine compound or a salt thereof that inhibits HER2 activity and exhibits brain transferability, and a pharmaceutical composition containing the same. A compound represented by the following general formula (I) or a salt thereof. (In the formula, R1 represents a C1-C4 alkyl group which may have a C1-C4 alkoxy group as a substituent, or a C3-C4 cycloalkyl group; R2 is a hydrogen atom, a halogen atom, Indicates a C1-C6 alkyl group or C1-C6 alkoxy group which may have 1 to 5 C1-C4 alkoxy groups or fluorine atoms as substituents; R3 is a hydrogen atom or a fluorine atom as a substituent. Indicates a C1-C4 alkyl group which may have 1 to 5; R4 indicates a hydrogen atom or a C1-C4 alkyl group; R5 represents 1 to 3 substituents selected from fluorine and chlorine atoms. Indicates a phenyl group that may have one.) |
priorityDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 259.